|Articles|March 1, 2015
- BioPharm International-03-01-2015
- Volume 28
- Issue 3
BioPharm International, March 2015 Issue (PDF)
Click the title above to open the BioPharm International March 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
USP Publishes Monoclonal Antibody Guidelinesalmost 11 years ago
Maintaining the Stability of Biologicsalmost 11 years ago
Springing Forwardalmost 11 years ago
Reinventing the Cold Chain in a High-Stakes Marketalmost 11 years ago
A Robust CAPA System for a Global Supply Chainalmost 11 years ago
CMOs Plan for Capacity Expansionsalmost 11 years ago
Vaccine Development and Production Challenges Manufacturersalmost 11 years ago
Detecting Protein Aggregates and Evaluating their Immunogenicityalmost 11 years ago
Re-use of Protein A Resin: Fouling and Economicsalmost 11 years ago
SEC in the Modern Downstream Purification ProcessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implementing Automation and Flexible Design for Allogeneic Manufacturing
2
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
